Part 2 of this series for Global Biosimilars Week dives into the complexities of payer and pharmacy benefit manager (PBM) ...

Anyone who needs insulin to treat diabetes knows that the cost of the drug has skyrocketed in the last few years. The reason for the sharp ...

In recent years, many patients like Mitchell have faced soaring insulin costs. These prices have been exacerbated by pharmacy benefit managers, or PBMs, middlemen between drug manufacturers and ...

PBMs negotiate drug prices and rebates with manufacturers for their employer and health plan customers. A Novo Nordisk ...

INSULIN LITIGATION DEEP-DIVE — As Congress weighs legislation to rein in pharmacy benefit managers, a lawsuit accusing PBMs and insulin makers of racketeering and unfair trade practices is ...

It claims that the PBMs have been rigging pharma supply chain competition in their favour in pursuit of profit, impairing patients' access to lower list price insulin products, and shifting the ...

Huge health conglomerates have another reason to worry that their business model might be disrupted. On a visit to Columbus Monday, one of the country’s top antitrust watchdogs said her agency is ...

PBMs negotiate drug prices and rebates with manufacturers for their employer and health plan customers. A Novo Nordisk ...

Criticism of prescription drug middlemen has intensified recently in the wake of a federal agency’s actions and legislative reform attempts. Georgia Gov. Brian Kemp, though, vetoed a related bill that ...

Ladies and gentlemen, thank you for standing-by, and welcome to the Lilly Q3 2024 Earnings Call. [Operator Instructions] I ...